Research on the relationship, screening and prevention of thrombophilia and thromboembolic disease in pregnancy

doi:10.3877/cma.j.issn.2095-3259.2023.02.002

Abstract

Abstract:

Thrombophilia refers to a pathological condition with an increased risk of thromboembolism due to the presence of various inherited or acquired factors, an increased coagulation potential unique to pregnancy, and a reduced anticoagulant activity resulting in the pregnancy itself being physiologically hypercoagulable, which, when combined with thrombophilia, increases the risk of thromboembolic disease during pregnancy. There is still controversy about the association of thrombophilia with complications during pregnancy, and this article mainly addresses the association between thrombophilia and thromboembolic disease of pregnancy.

Key words: Thromboembolism, Thrombosis, Pregnancy

Qitao Huang, Mei Zhong. Research on the relationship, screening and prevention of thrombophilia and thromboembolic disease in pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2023, 12(02): 71-75.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2023.02.002

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2023/V12/I02/71

References 35

[1]	董艳玲，漆洪波. ACOG"妊娠期遗传性易栓症指南(2018)"解读[J]. 中国实用妇科与产科杂志，2019，35(3)：298-303.
[2]	中华医学会血液学分会血栓与止血学组. 易栓症诊断与防治中国指南(2021年版)[J]. 中华血液学杂志，2021，42(11): 881-888.
[3]	Chiasakul T，De Jesus E，Tong J，et al. Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis[J]. Journal of the American Heart Association，2019，8(19)：1-51.
[4]	Skeith L. Preventing venous thromboembolism during pregnancy and postpartum: crossing the threshold[J]. Hematology Am Soc Hematol Educ Program，2017，2017(1)：160-167.
[5]	徐琴，周容. 妊娠期及产褥期静脉血栓栓塞症的流行病学特征及发生机制[J]. 实用妇产科杂志，2022，38(5)：321-324.
[6]	Noguchi K，Nakazono E，Tsuda T，et al. Plasma phenotypes of protein S Lys196Glu and protein C Lys193del variants prevalent among young Japanese women[J]. Blood Coagulation & Fibrinolysis，2019，30(8)：393-400.
[7]	Padda J，Khalid K，Mohan A，et al. Factor V Leiden G1691A and prothrombin gene G20210A mutations on pregnancy outcome[J]. Cureus，2021，13(8)：1-8.
[8]	Bezgin T，Kaymaz C，Akbal Ö，et al. Thrombophilic gene mutations in relation to different manifestations of venous thromboembolism: a single tertiary center study[J]. Clinical and Applied Thrombosis/Hemostasis，2018，24(1)：100-106.
[9]	American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins-Obstetries. ACOG Practice Bulletin No.197: inherited thrombophilias in pregnancy[J]. Obstet Gynecol，2018，132(1)：e18-e34.
[10]	Croles FN，Nasserinejad K，Duvekot JJ，et al. Pregnancy，thrombophilia，and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis[J]. BMJ，2017，359：1-28.
[11]	Raia-Barjat T，Edebiri O，Chauleur C. Venous thromboembolism risk score and pregnancy[J]. Frontiers in Cardiovascular Medicine，2022，9：1-8.
[12]	Martinelli I，De Stefano V. Rare thromboses of cerebral，splanchnic and upper-extremity veins. a narrative review[J]. Thromb Haemost，2010，103(6)：1136-1144.
[13]	Abbattista M，Capecchi M，Martinelli I. Treatment of unusual thrombotic manifestations[J]. Blood，2020，135(5)：326-334.
[14]	Lauw MN，Barco S，Coutinho JM，et al. Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis[J]. Seminars in Thrombosis and Hemostasis，2013，39(8)：913-927.
[15]	Kumar R，Vinny PW，Nair VG，et al. Comprehensive thrombophilia evaluation in cerebral venous thrombosis: a single center cross sectional study[J]. Indian Journal of Hematology and Blood Transfusion，2022，38(3)：522-528.
[16]	Martinelli I，De Stefano V. Rare thromboses of cerebral，splanchnic and upper-extremity veins. a narrative review[J]. Thromb Haemost，2010，103(6)：1136-1144.
[17]	Lussana F，Dentali F，Ageno W，et al. Venous thrombosis at unusual sites and the role of thrombophilia[J]. Seminars in Thrombosis and Hemostasis，2007，33(6)：582-587.
[18]	Iorio A，Barnes C，Vedovati MC，et al. Thrombophilia and cerebral vein thrombosis[J]. Frontiers of neurology and neuroscience，2008，23：55-76.
[19]	Dentali F，Galli M，Gianni M，et al. Inherited thrombophilic abnormalities and risk of portal vein thrombosis[J]. Thrombosis and Haemostasis，2017，99(4)：675-682.
[20]	Subri IM, Yusof ZAM, Zainal NZ, et al. Role of porcine base anticoagulant during pregnancy and puerperium as prophylaxis treatment in venous thromboembolism (VTE): Shariah views and perspectives[J]. International journal of recent technology and engineering，2019，8(2S11)：567-574.
[21]	中华医学会围产医学分会．产科抗磷脂综合征诊断与处理专家共识[J]. 中华围产医学杂志，2020，23(8)：517-522.
[22]	Bundhun PK，Soogund MZS，Huang F. Arterial/venous thrombosis，fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis[J]. BMC Pregnancy and Childbirth，2018，18(1)：1-13.
[23]	Ruiz-Irastorza G，Crowther M，Branch W，et al. Antiphospholipid syndrome[J]. Lancet，2010，376(9751)：1498-1509.
[24]	Glasnovic M，Bosnjak I，Vcev A，et al. Vascular thrombosis associated with antiphospholipide syndrome[J]. Coll Antropol，2008，32(1)：103-107.
[25]	Högdén A，Antovic A，Berg E，et al. Obstetric outcomes in patients with primary thrombotic and obstetric antiphospholipid syndrome and its relation to the antiphospholipid antibody profile[J]. Lupus，2019，28(7): 868-877.
[26]	Saccone G，Berghella V，Maruotti GM，et al. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study[J]. Am J Obstet Gynecol，2017，216(5)：521-525.
[27]	Tonello M，Calligaro A，Favaro M，et al. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics[J]. Archives of Gynecology and Obstetrics，2021，303(2)：455-461.
[28]	Cervera R，Serrano R，Pons-Estel GJ，et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients[J]. Annals of the Rheumatic Diseases，2015，74(6)：1011-1018.
[29]	Jerez-Lienas A，Mathian A，Aboab J，et al. Cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature[J]. Brain Sciences，2021，11(12)：1-24.
[30]	Connors JM. Thrombophilia testing and venous thrombosis[J]. N Engl J Med，2017，377(12)：1177-1187.
[31]	Shlomo M，Gorodischer R，Daniel S，et al. The fetal safety of enoxaparin use during pregnancy: a population-based retrospective cohort study[J]. Drug Safety，2017，40(11)：1147-1155.
[32]	Jacobson B，Rambiritch V，Paek D，et al. Safety and efficacy of enoxaparin in pregnancy: a systematic review and meta-analysis[J]. Advances in Therapy，2020，37(1)：27-40.
[33]	中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识[J]. 中华妇产科杂志，2021，56(4)：236-243.
[34]	刘真，孙瑜. 妊娠期及产褥期静脉血栓栓塞疾病诊治：2015英国皇家妇产科医师学会指南解读[J]. 中华围产医学杂志，2017(12)：841-845.
[35]	沈丽霞，王子莲. 妊娠期和产褥期静脉血栓栓塞的预防：2020年昆士兰临床指南解读[J]. 中国实用妇科与产科杂志，2021，37(2)：208-210.

Please choose a citation manager

Content to export